Newly diagnosed primary open-angle glaucoma randomized to 2 trabecular bypass stents or prostaglandin: outcomes through 36 months

To examine outcomes through 36 months in phakic eyes with newly diagnosed primary open-angle glaucoma (POAG) naïve to therapy randomized to treatment with two trabecular micro-bypass stents or topical prostaglandin.

Saved in:

Bibliographic Details
Main Authors:	Vold, Steven D. (Author) , Voskanyan, Lilit (Author) , Tetz, Manfred (Author) , Auffarth, Gerd U. (Author) , Masood, Imran (Author) , Au, Leon (Author) , Ahmed, Iqbal Ike K. (Author) , Saheb, Hady (Author)
Format:	Article (Journal)
Language:	English
Published:	September 12, 2016
In:	Ophthalmology and therapy Year: 2016, Volume: 5, Issue: 2, Pages: 161-172
ISSN:	2193-6528
DOI:	10.1007/s40123-016-0065-3
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s40123-016-0065-3
Author Notes:	Steven D. Vold, Lilit Voskanyan, Manfred Tetz, Gerd Auffarth, Imran Masood, Leon Au, Iqbal Ike K. Ahmed, Hady Saheb

Description
Summary:	To examine outcomes through 36 months in phakic eyes with newly diagnosed primary open-angle glaucoma (POAG) naïve to therapy randomized to treatment with two trabecular micro-bypass stents or topical prostaglandin.
Item Description:	Gesehen am 04.06.2020
Physical Description:	Online Resource
ISSN:	2193-6528
DOI:	10.1007/s40123-016-0065-3